This finding contrasts with recent literature demonstrating that carbohydrate-restricted diets can be used to de-escalate or avoid GLP-1 RA prescriptions [40] and support T2D remission, defined as HbA1c <6.5% at least 3 months after stopping glucose-lowering medications [9, 41]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.